{"denomUnitsSelected":"Participants","description":"The two-sample log-rank test will be performed.","reportingStatus":"NOT_POSTED","timeFrame":"Up to 10 years","title":"Patient Outcomes Based on (Vincristine, Dactinomycin, and Cyclophosphamide [VAC]/Vincristine and Irinotecan [VI] With or Without Temsirolimus) Who Have Received Maintenance Therapy on ARST1431 to Those Who Received VAC/VI on ARST0531","type":"OTHER_PRE_SPECIFIED"}